Oyler J, Darwin W D, Preston K L, Suess P, Cone E J
Addiction Research Center, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, USA.
J Anal Toxicol. 1996 Oct;20(6):453-62. doi: 10.1093/jat/20.6.453.
The analysis of meconium for cocaine and metabolites has proved to be a reliable method for the detection of fetal cocaine exposure. Better sensitivity and a larger gestational window of detection have been demonstrated for meconium testing as compared with neonatal urine testing. Cocaine and cocaine metabolites, including benzoylecgonine, ecgonine methyl ester, cocaethylene, norcocaine, benzoylnorecgonine, and m-hydroxybenzoylecgonine, have been identified in meconium. The origin of these metabolites, whether maternal or fetal, has not been established. This study was conducted to compare the disposition of cocaine and metabolites in meconium from fetuses exposed to cocaine with that of urine from cocaine abusers. Meconium specimens were obtained from six neonates of mothers positive for cocaine use by urinalysis or self-reporting or both during pregnancy. Urine specimens were obtained from 17 adult female and 17 adult male cocaine users enrolled in a treatment program. Specimens were analyzed by gas chromatography-mass spectrometry for cocaine and 12 related analytes. The following analytes were identified and measured in meconium and urine: anhydroecgonine methyl ester; ecgonine methyl ester; ecgonine ethyl ester; cocaine; cocaethylene; benzoylecgonine; norcocaine; norcocaethylene; benzoylnorecgonine; m-and p-hydroxycocaine; and m-and p-hydroxybenzoylecgonine. In addition, both m-and p-hydroxybenzoylecgonine were found to exhibit approximately equal cross-reactivity with benzoylecgonine in the EMIT and TDx assays. The presence of p-hydroxybenzoylecgonine in meconium suggested that this newly identified metabolite, like m-hydroxybenzoylecgonine, might serve as a valuable marker of fetal cocaine exposure during pregnancy. The presence of cocaine and anhydroecgonine methyl ester in meconium was attributed to transfer across the placenta from the mother. However, the origin of the hydrolytic and oxidative metabolites of cocaine could not be established because they were also identified in urine specimens of adult female cocaine users and could have arisen in meconium from either fetal or maternal metabolism.
对胎粪中的可卡因及其代谢物进行分析已被证明是检测胎儿可卡因暴露的可靠方法。与新生儿尿液检测相比,胎粪检测已显示出更高的灵敏度和更大的检测孕周范围。在胎粪中已鉴定出可卡因及其代谢物,包括苯甲酰芽子碱、芽子碱甲酯、可卡因乙烯、去甲可卡因、苯甲酰去甲芽子碱和间羟基苯甲酰芽子碱。这些代谢物的来源,无论是母体还是胎儿,尚未确定。本研究旨在比较暴露于可卡因的胎儿胎粪中可卡因及其代谢物的处置情况与可卡因滥用者尿液中的处置情况。胎粪样本取自六名母亲在孕期经尿液分析或自我报告或两者均显示可卡因使用呈阳性的新生儿。尿液样本取自参与一个治疗项目的17名成年女性和17名成年男性可卡因使用者。样本通过气相色谱-质谱法分析可卡因及12种相关分析物。在胎粪和尿液中鉴定并测量了以下分析物:脱水芽子碱甲酯;芽子碱甲酯;芽子碱乙酯;可卡因;可卡因乙烯;苯甲酰芽子碱;去甲可卡因;去甲可卡因乙烯;苯甲酰去甲芽子碱;间和对羟基可卡因;以及间和对羟基苯甲酰芽子碱。此外,发现在EMIT和TDx分析中间羟基苯甲酰芽子碱和对羟基苯甲酰芽子碱与苯甲酰芽子碱表现出大致相等的交叉反应性。胎粪中对羟基苯甲酰芽子碱的存在表明,这种新鉴定出的代谢物,与间羟基苯甲酰芽子碱一样,可能是孕期胎儿可卡因暴露的有价值标志物。胎粪中可卡因和脱水芽子碱甲酯的存在归因于从母体经胎盘转运。然而,可卡因水解和氧化代谢物的来源无法确定,因为它们也在成年女性可卡因使用者的尿液样本中被鉴定出,并且可能在胎粪中由胎儿或母体代谢产生。